198 related articles for article (PubMed ID: 16848843)
1. Overdiagnosis, sojourn time, and sensitivity in the Copenhagen mammography screening program.
Olsen AH; Agbaje OF; Myles JP; Lynge E; Duffy SW
Breast J; 2006; 12(4):338-42. PubMed ID: 16848843
[TBL] [Abstract][Full Text] [Related]
2. Mammography screening for breast cancer in Copenhagen April 1991-March 1997. Mammography Screening Evaluation Group.
Lynge E
APMIS Suppl; 1998; 83():1-44. PubMed ID: 9850674
[TBL] [Abstract][Full Text] [Related]
3. Age-specific interval breast cancers in New South Wales and meta-analysis of studies of women aged 40-49 years.
Taylor R; Page A; Bampton D; Estoesta J; Rickard M
J Med Screen; 2004; 11(4):199-206. PubMed ID: 15563775
[TBL] [Abstract][Full Text] [Related]
4. Estimates of overdiagnosis of invasive breast cancer associated with screening mammography.
Morrell S; Barratt A; Irwig L; Howard K; Biesheuvel C; Armstrong B
Cancer Causes Control; 2010 Feb; 21(2):275-82. PubMed ID: 19894130
[TBL] [Abstract][Full Text] [Related]
5. Estimating mean sojourn time and screening test sensitivity in breast cancer mammography screening: new results.
Weedon-Fekjaer H; Vatten LJ; Aalen OO; Lindqvist B; Tretli S
J Med Screen; 2005; 12(4):172-8. PubMed ID: 16417693
[TBL] [Abstract][Full Text] [Related]
6. Breast cancer incidence after the introduction of mammography screening: what should be expected?
Svendsen AL; Olsen AH; von Euler-Chelpin M; Lynge E
Cancer; 2006 May; 106(9):1883-90. PubMed ID: 16572411
[TBL] [Abstract][Full Text] [Related]
7. Seventeen-years overview of breast cancer inside and outside screening in Denmark.
Domingo L; Jacobsen KK; von Euler-Chelpin M; Vejborg I; Schwartz W; Sala M; Lynge E
Acta Oncol; 2013 Jan; 52(1):48-56. PubMed ID: 22943386
[TBL] [Abstract][Full Text] [Related]
8. Does educational level determine screening participation?
von Euler-Chelpin M; Olsen AH; Njor S; Jensen A; Vejborg I; Schwartz W; Lynge E
Eur J Cancer Prev; 2008 Jun; 17(3):273-8. PubMed ID: 18414200
[TBL] [Abstract][Full Text] [Related]
9. Balancing sensitivity and specificity: sixteen year's of experience from the mammography screening programme in Copenhagen, Denmark.
Utzon-Frank N; Vejborg I; von Euler-Chelpin M; Lynge E
Cancer Epidemiol; 2011 Oct; 35(5):393-8. PubMed ID: 21239242
[TBL] [Abstract][Full Text] [Related]
10. Estimating lead time and sensitivity in a screening program without estimating the incidence in the screened group.
Straatman H; Peer PG; Verbeek AL
Biometrics; 1997 Mar; 53(1):217-29. PubMed ID: 9147591
[TBL] [Abstract][Full Text] [Related]
11. Predicting the risk of a false-positive test for women following a mammography screening programme.
Njor SH; Olsen AH; Schwartz W; Vejborg I; Lynge E
J Med Screen; 2007; 14(2):94-7. PubMed ID: 17626709
[TBL] [Abstract][Full Text] [Related]
12. Estimating mean sojourn time and screening sensitivity using questionnaire data on time since previous screening.
Weedon-Fekjaer H; Lindqvist BH; Vatten LJ; Aalen OO; Tretli S
J Med Screen; 2008; 15(2):83-90. PubMed ID: 18573776
[TBL] [Abstract][Full Text] [Related]
13. Participation behaviour following a false positive test in the Copenhagen mammography screening programme.
Andersen SB; Vejborg I; von Euler-Chelpin M
Acta Oncol; 2008; 47(4):550-5. PubMed ID: 18465321
[TBL] [Abstract][Full Text] [Related]
14. Service screening with mammography in Northern Sweden: effects on breast cancer mortality - an update.
Jonsson H; Bordás P; Wallin H; Nyström L; Lenner P
J Med Screen; 2007; 14(2):87-93. PubMed ID: 17626708
[TBL] [Abstract][Full Text] [Related]
15. [Mammography screening in the county of Copenhagen. Results of the first three screening rounds].
Tange UB; Hirsch FR; Jensen MB; Olsen AH; Blichert-Toft M; Rank FE; Vejborg IM; Mouridsen H; Lynge E
Ugeskr Laeger; 2002 Feb; 164(8):1048-52. PubMed ID: 11894707
[TBL] [Abstract][Full Text] [Related]
16. Pattern of participation in a cohort aged 50-60 years at first invitation to the service-screening programme with mammography in Stockholm county, Sweden.
Törnberg S; Kemetli L; Svane G; Rosén M; Stenbeck M; Nyström L
Prev Med; 2005; 41(3-4):728-33. PubMed ID: 16137757
[TBL] [Abstract][Full Text] [Related]
17. Interval cancer incidence and episode sensitivity in the Norrbotten Mammography Screening Programme, Sweden.
Bordás P; Jonsson H; Nyström L; Lenner P
J Med Screen; 2009; 16(1):39-45. PubMed ID: 19349530
[TBL] [Abstract][Full Text] [Related]
18. Overdiagnosis and overtreatment of breast cancer: microsimulation modelling estimates based on observed screen and clinical data.
de Koning HJ; Draisma G; Fracheboud J; de Bruijn A
Breast Cancer Res; 2006; 8(1):202. PubMed ID: 16524452
[TBL] [Abstract][Full Text] [Related]
19. Comparing sensitivity and specificity of screening mammography in the United States and Denmark.
Kemp Jacobsen K; O'Meara ES; Key D; S M Buist D; Kerlikowske K; Vejborg I; Sprague BL; Lynge E; von Euler-Chelpin M
Int J Cancer; 2015 Nov; 137(9):2198-207. PubMed ID: 25944711
[TBL] [Abstract][Full Text] [Related]
20. Scheduling mammography screening for the early detection of breast cancer in Korean women.
Lee SY; Jeong SH; Kim J; Jung SH; Song KB; Nam CM
J Med Screen; 2007; 14(4):205-9. PubMed ID: 18078566
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
